Media & Press Updates


TAIWAN: Has Reported 5 Days in a Row Without Any New Cases of COVID-19

The Central Epidemic Command Center (CECC) of Taiwan has announced that no additional cases of coronavirus disease 2019 (COVID-19) were confirmed on May 5. The CECC reported that 530 additional cases related to COVID-19 were reported on May 4. As of writing, a cumulative total of 64,958 cases have been reported among which COVID-19 has been ruled out in 63,587. Of these reported cases, infection with COVID-19 was laboratory-confirmed in 438 cases. Of 438 confirmed cases in Taiwan, 347 are imported and 55 are indigenous while 36 are naval personnel aboard the Panshi fast combat support ship. Of the confirmed cases, there have been 6 deaths, and 334 patients have been released from isolation, […]

For COVID-19 Isolation: Our MagCore® Viral Nucleic Acid Extraction Kit (High Sensitivity) is Your Best Option Available

At RBC Bioscience, we are always keen to innovate and improve our products and services, hence we have developed a Special Protocol in joint with the Taiwan Centers for Disease Control (CDC)  to be used with our MagCore® Viral Nucleic Acid Extraction Kit (High Sensitivity) Code 203 for the isolation of  COVID-19. Please do not hesitate to contact us to inquire more about it. RBC Bioscience, we make life better.

MagCore® triXact RNA Kit

This kit is specially designed for total RNA extraction from cultured cells, whole blood and tissues, by making use of its outstanding performance, efficiency and easy-to-follow protocols to simplify your every day extractions. Please contact us for more information!


We are very pleased to announce that we will have a booth at Analytica 2020 exhibition in Munich, Germany. The exhibition will begin on March 31st and will end on April 3rd 2020. This year, we have very exciting news to share with you! We cordially invite you to visit us at our stand which will be located at Hall A3 and our Booth No. is 504. We are looking forward to see you there!!!

MagCore® Products Being Used for a Carcinoma Gene Bank Project at CMUH

China Medical University Hospital (CMUH) is the biggest hospital in Taiwan in where they are currently building up a Carcinoma Gene Bank and over a million tests will be done for this project by using 12 MagCore® Super instruments to perform the runs. On the following video, you will find our MagCore® Super machines being featured in the minute 2:11: RBC Bioscience, making life better.

Circulating DNA Large Volume Kit (4ml) CODE 115 Promotion Price!!!

Our newest kit is available and having a super special promotion price until the end of this year!!!! Exclusively designed for extraction of cfDNA from 4ml plasma or serum. Please contact us for more information or click here to know more about it!!! 115 Kit DM *An additional purchase of a T-Rack 5ml is needed for all MagCore® instruments.

MagCore® Viral Nucleic Acid Extraction Kit (High Sensitivity) Code 203 is Available Now!!!

This kit is designed to isolate viral DNA and/or RNA from plasma, serum, swabs and cell-free body fluids. All plastic consumables included in the kit are DNase/RNase-free to minimize the risk of cross contamination. It also features Internal Control selection in its protocol, being compatible with any viral detection kit.  Please contact us for more information about it!

605 Kit is Available Now!!! MagCore®Total RNA FFPE One-Step Kit

It features the method one-step heating, to melt paraffin without harmful reagents involved such as xylene or other organic solvents, and lyses tissues at the same time. The program provides optional DNase I treatment to remove contaminated DNA and also uses magnetic- particle technology to purify total RNA from FFPE tissues. The purified RNA can be directly used for downstream applications such as real-time PCR, RT-PCR, cDNA synthesis, etc. Please do not hesitate to contact us for more information about this kit!

Assessing the Diagnostic Value of Plasma- cfDNA in Prostate Cancer Screening

Prostate cancer is the second form of cancer among men worldwide. For early cancer detection, we should identify tumors in initial stages before the physical signs become visible. We invite you to take a look at the following article to learn how our products are helping out to conduct such important studies here: Assessing the Diagnostic Value of Plasma- cfDNA in Prostate Cancer Screening